Fundamentals of Chemotherapy Immunotherapy
Administration
Terms in this set (89)
-cancer that begins in bone marrow or immune system
Hematologic cancer (blood
cells.
cancer)
-Ex: leukemia, lymphoma, multiple myeloma
cancer starts in blood-forming tissues like bone marrow
Leukemia -causes lots of abnormal blood cells to be produced
and enter bloodstream
-cancer that begins in immune system
(WBC=lymphocytes)
-hodgkin and non-hodgkins
Lymphoma -B lymphocytes (B cells) - make antibodies (bacteria and
viruses, most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy
germs and abnormal cells
Reed-Sternberg cell (cancer cells in classic)
Hodgkin lymphoma
-typically starts in B cells
-large, diverse group of cancers in immune system cells
Non-Hodgkin's Lymphoma
-indolent (slow growing) or aggressive (fast)
Myeloma Cancer in plasma cells (WBC that produce antibodies)
All antineoplastic agents used to treat cancer, given
through oral and parenteral routes or other routes as
Chemotherapy
specified in the standard, not including hormonal
therapies.
Who can order Written and signed by licensed independent
chemotherapy? practitioners (MD/DO, PA, Oncology NP)
, Can you use verbal orders NO! Only when holding/stopping admin.
for chemotherapy?
Who can mix Pharmacist, Pharmacy tech, MD/DO, qualified RN
Chemotherapy?
Who can administer Registered Nurses with specialized education, prep and
chemotherapy? training. See specific state laws and statutes
How often is chemo Annual continuing ed and competency assessment is
competency reassessed> recommended
-confirm plan with patient
What is the dose -two practitioners verify: drug name, dose, volume, rate,
verification process? route, expiration date, appearance
-document verification in chart
-Gloves: two pairs, HD tested
What PPE is required for IV -Gown: disposable, back closed, long sleeved
Chemotherapy? -Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy Chemo BEFORE primary treatment (common in breast
(tumor burden) and colon)
Chemo AFTER primary treatment (common in solid
Adjuvant therapy
tumor)
soft, sponge-like tissue in center of most bones,
Bone Marrow
produce WBC, RBC, and platelets.
bone marrow activity is decreased, causing less RBC,
Myelosuppression
WBC and Platelets.
Myeloablation severe myelosuppression
initial phase, typically in hospital, intended
Induction phase
myelosuppression
Consolidation phase after successful induction, kills cancer cells left in body
(intensification/postremissio (ex radiation, stem cell transplant)
n therapy)
Administration
Terms in this set (89)
-cancer that begins in bone marrow or immune system
Hematologic cancer (blood
cells.
cancer)
-Ex: leukemia, lymphoma, multiple myeloma
cancer starts in blood-forming tissues like bone marrow
Leukemia -causes lots of abnormal blood cells to be produced
and enter bloodstream
-cancer that begins in immune system
(WBC=lymphocytes)
-hodgkin and non-hodgkins
Lymphoma -B lymphocytes (B cells) - make antibodies (bacteria and
viruses, most common lymphoma
-T lymphocytes (T cells) - boost/slow immune, destroy
germs and abnormal cells
Reed-Sternberg cell (cancer cells in classic)
Hodgkin lymphoma
-typically starts in B cells
-large, diverse group of cancers in immune system cells
Non-Hodgkin's Lymphoma
-indolent (slow growing) or aggressive (fast)
Myeloma Cancer in plasma cells (WBC that produce antibodies)
All antineoplastic agents used to treat cancer, given
through oral and parenteral routes or other routes as
Chemotherapy
specified in the standard, not including hormonal
therapies.
Who can order Written and signed by licensed independent
chemotherapy? practitioners (MD/DO, PA, Oncology NP)
, Can you use verbal orders NO! Only when holding/stopping admin.
for chemotherapy?
Who can mix Pharmacist, Pharmacy tech, MD/DO, qualified RN
Chemotherapy?
Who can administer Registered Nurses with specialized education, prep and
chemotherapy? training. See specific state laws and statutes
How often is chemo Annual continuing ed and competency assessment is
competency reassessed> recommended
-confirm plan with patient
What is the dose -two practitioners verify: drug name, dose, volume, rate,
verification process? route, expiration date, appearance
-document verification in chart
-Gloves: two pairs, HD tested
What PPE is required for IV -Gown: disposable, back closed, long sleeved
Chemotherapy? -Respirator: NIOSH approved
-Eye & Face: face shield/mask
Neoadjuvant therapy Chemo BEFORE primary treatment (common in breast
(tumor burden) and colon)
Chemo AFTER primary treatment (common in solid
Adjuvant therapy
tumor)
soft, sponge-like tissue in center of most bones,
Bone Marrow
produce WBC, RBC, and platelets.
bone marrow activity is decreased, causing less RBC,
Myelosuppression
WBC and Platelets.
Myeloablation severe myelosuppression
initial phase, typically in hospital, intended
Induction phase
myelosuppression
Consolidation phase after successful induction, kills cancer cells left in body
(intensification/postremissio (ex radiation, stem cell transplant)
n therapy)
